We are delighted to inform you that our CEO, Dr. Vince Gao, presented a compelling talk titled “The Application of Biological Pathway Omics in Extending Healthy Lifespan” at the 19th International Conference on Genomics (ICG-19-THA), held at Chulalongkorn University in Bangkok on May 19, 2024. His presentation offered a deep dive into our cutting-edge research aimed at understanding and influencing the mechanisms of aging through our U.S. patented Biological Pathway Omics (BPO®) technology.
Purpose of Our Research:
Dr. Gao’s talk emphasized our ongoing commitment to slowing down the aging process and even the potential reversal of Biological Age (BA) that mirrors physiological dynamics. Through meticulous research, we’re uncovering how molecular changes in key biological pathways can impact cellular, tissue, organ, and overall body functions.
Our Value Proposition:
During the presentation, Dr. Gao detailed how our BPO® technology allows us not only to visualize but also to reverse the signs of aging before and after specific interventions. By addressing aging at its molecular roots, we aim to help individuals feel younger, more energetic, and significantly reduce the risks of age-related diseases. Investing in this technology means investing in a longer, healthier, and higher quality of life.
Technology Highlights:
- Biological Pathway Omics (BPO®) Technology – Our proprietary technology has been developed to study the molecular changes occurring across three significant biological pathways. This scientific advancement forms the basis for our personalized solutions aimed at reversing biological age.
- Personalized Intervention – Based on our BPO® technology, we offer personalized intervention models tailored to individual genetic profiles. These interventions are grounded in robust scientific research and have shown promising results in restoring the vitality and functional capacities akin to a younger biological age.